An interventional study of the smart watch and Samsung Health app in Obstructive Sleep Apnea of Adult, Positive Airway Pressure and Adherence, Treatment, sponsored by Seoul National University Hospital. Completed at 1 site in South Korea. Open to participants aged 22 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-04-24.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment
Continuous positive airway pressure (CPAP) is highly effective in treating obstructive sleep apnea (OSA). However, this treatment modality relies heavily on patient adherence, and poor adherence to the treatment limits its effectiveness in treating OSA. Strategies to augment adherence are needed in the management of OSA.
The smart watch and linked app provide various health information, including sleep, snoring or oxygen saturation during sleep, exercise, blood pressure, and electrocardiogram. The smart watch and linked app could potentially improve adherence to positive airway pressure (PAP) treatment.
This randomized controlled trial (RCT) aimed to examine whether the use of smart watch and app can increase PAP adherence in patients with OSA.
114 studies on the registry are indexed under Treatment Adherence and Compliance; 60 are open to participants now.
This study's enrollment of 46 is below the median of 84 across 97 interventional studies indexed under Treatment Adherence and Compliance.
Browse Treatment Adherence and Compliance studies →Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The user of the smart watch and Samsung Health app
Device: the smart watch and Samsung Health app
No use of both the smart watch and Samsung Health app
Use the smart watch (Galaxy Watch 4, Samsung Electronics Co., Ltd., Korea) and the Samsung Health app (Samsung Electronics Co., Ltd., Korea) for 90 days of positive airway pressure treatment
Average daily usage of PAP (all days)
Average daily usage of PAP (all days) in 90 days
Time frame: 90 days
Average daily usage of PAP (days used)
Average daily usage of PAP (days used) in 90 days
Time frame: 90 days
Percentage of days using PAP
Percentage of days using PAP
Time frame: 90 days
Percentage of days using PAP ≥ 4 hours
Percentage of days using PAP ≥ 4 hours
Time frame: 90 days
Percentage of patients meeting the National Health Insurance Service adherence criteria
The National Health Insurance Service adherence criteria: ≥ 4 hours of use on ≥ 70% of days over 30 consecutive days during the 90 days of PAP therapy
Time frame: 90 days
Changes of the scores of Epworth Sleepiness Scale
Changes of the scores of Epworth Sleepiness Scale
Time frame: 90 days
Changes of the scores of Pittsburgh Sleep Quality Index
Changes of the scores of Pittsburgh Sleep Quality Index (an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality)
Time frame: 90 days
Patient satisfaction with PAP therapy
Patient satisfaction with PAP therapy
Time frame: 90 days
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Treatment Adherence and Compliance→
Seoul National University Hospital